Does Beta Glucan Upper Respiratory Infection Randomized Trial work?

The current Migaku evidence database contains 2 reusable source documents for Beta Glucan Upper Respiratory Infection Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove. - However, clinical evidence linking their intake to site-specific upper respiratory mucosal immune health in humans remains limited. [Kanno T (2026); evidence level 2] - SC-BG intake also attenuated declines in s-IgA levels in the posterior oropharyngeal wall and nasopharynx and increased salivary lysozyme concentrations. [Kanno T (2026); evidence level 2] - Background/Objective : Dietary polysaccharides are increasingly recognized as functional nutritional components that support human health through modulation of immune function. [Kanno T (2026); evidence level 2] - By interacting with innate pattern recognition receptors (PRRs), including Dectin-1 and Toll-like receptors (TLRs), expressed on gut-associated lymphoid tissue (GALT) and immune cells, β-1,3-glucans regulate both innate and adaptive immune responses [,]. [Samiksha Fnu (2026); evidence level 4] - Table 2 A summary of β-glucans derived from different fungal sources and their associated therapeutic properties is provided in. [Samiksha Fnu (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.